271 results Edouard d'Anterroches Partner Luxembourg Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels. Webinar 'Tax news for Private Equity and Venture Capital firms' The NVP and Stibbe are organising the webinar 'Tax news for Private Equity and Venture Capital firms' on Thursday 2 December from 4 pm to 5.15 pm. Webinar: SPACs from a Belgian perspective On 22 June 2021, Pascal Vanden Borre and Willem Witters host a webinar on SPAC's for the members of the Practice Group Corporate of IBJ/IJE. Stibbe advises Vestar Capital Partners Advising on the sale of one of the world's largest manufacturers of wheelchairs, Sunrise Medical, to Equistone Partners Europe. Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital. Stibbe advises Silver Lake Advising private equity investor Silver Lake on the EUR 1 billion acquisition of Global Blue. Stibbe advises UCC Holdings Co Advising the Japanese coffee company UCC Holdings Co. on the acquisition of United Coffee (formerly the Dutch "Three Moles") from CapVest Equity Partners. Nina Coussement Associate Brussels Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products. Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments. Stibbe advises on the contemplated IPO of Agendia Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products. Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency. Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors. Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations. Stibbe advises on the IPO of Tornier Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix. Pagination Previous page Page 13 Current page 14 Page 15 Page 16 Next page
Stibbe advises KBC Securities Stibbe assisted KBC Securities as underwriters on the IPO of ThromboGenics on Euronext Brussels.
Webinar 'Tax news for Private Equity and Venture Capital firms' The NVP and Stibbe are organising the webinar 'Tax news for Private Equity and Venture Capital firms' on Thursday 2 December from 4 pm to 5.15 pm.
Webinar: SPACs from a Belgian perspective On 22 June 2021, Pascal Vanden Borre and Willem Witters host a webinar on SPAC's for the members of the Practice Group Corporate of IBJ/IJE.
Stibbe advises Vestar Capital Partners Advising on the sale of one of the world's largest manufacturers of wheelchairs, Sunrise Medical, to Equistone Partners Europe.
Stibbe advises Merin (formerly Uni-Invest) Advising Merin (formerly Uni-Invest) on the restructuring of its of its approximately EUR 790 million outstanding CMBS and Mezzanine loans and the sale of the company to Patron Capital and TPG Capital.
Stibbe advises Silver Lake Advising private equity investor Silver Lake on the EUR 1 billion acquisition of Global Blue.
Stibbe advises UCC Holdings Co Advising the Japanese coffee company UCC Holdings Co. on the acquisition of United Coffee (formerly the Dutch "Three Moles") from CapVest Equity Partners.
Stibbe advises leading plasma protein biotherapeutics company Stibbe advised a plasma protein biotherapeutics company on Belgium's implementation of a new Act on public procurement law that obliges Belgian hospitals to conduct a public procurement process for public contracts for the supply of medicinal products.
Stibbe advises leading private equity player Stibbe advised a leading European private equity player on Luxembourg corporate and finance matters related to numerous investments.
Stibbe advises biotech company Stibbe advised a leading biotechnology company on the legal aspects of clinical trials development for biotech medicinal products.
Stibbe advises major pharmaceutical company Stibbe assisted a global innovative pharmaceutical company in a complex co-marketing and co-promotion agreement and advised it on the impact of an innovative product’s registration at the European Medicines Agency.
Stibbe advises worldwide seeds leader Stibbe assisted a worldwide seeds leader in negotiations on cooperation deals with competitors.
Stibbe advises pharmaceutical multinational Stibbe assisted a pharmaceutical multinational in complex litigations.
Stibbe advises Cellerix Stibbe assisted Cellerix with its merger with Euronext-Brussels-listed Tigenix.